Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

101112131415161718

AstraZeneca pulls UK investment after dispute over Government support

31st Jan 2025 18:20

(Alliance News) - AstraZeneca PLC has cancelled a planned GBP450 million investment in a vaccine manufacturing plant in Merseyside, saying Labour failed to match the previous government's offer of support. Read More

UK earnings, trading statements calendar - next 7 days

30th Jan 2025 11:26

Read More

EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO

28th Jan 2025 13:43

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced in the past week and not separately reported by Alliance News: Read More

AstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in US

28th Jan 2025 07:00

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday celebrated another approval of their cancer drug Enhertu. Read More

LONDON BRIEFING: Stocks rise, Japan interest rates do likewise

24th Jan 2025 07:53

(Alliance News) - Stocks were called to open higher in London on Friday morning, although UK consumer confidence has reportedly suffered a steep fall in recent weeks. Read More

AstraZeneca makes USD570 million investment in Canada in pipeline push

23rd Jan 2025 20:34

(Alliance News) - AstraZeneca PLC on Thursday announced a USD570 million investment in Canada, creating more than 700 jobs, across all areas of the business. Read More

LONDON BROKER RATINGS: Jefferies raises Spirax; Peel Hunt cuts Grainger

20th Jan 2025 09:56

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

AstraZeneca and Daiichi's Datroway wins US FDA breast cancer approval

20th Jan 2025 08:38

(Alliance News) - AstraZeneca PLC on Monday said Datroway has been approved in the US for patients with a type of breast cancer. Read More

LONDON BRIEFING: Stocks down; BT's Openreach unveils network expansion

20th Jan 2025 07:56

(Alliance News) - The FTSE 100 was called to open down on Monday morning, ahead of Donald Trump's first day as 47th US president. Read More

AstraZeneca's Calquence gets US approval for mantle cell lymphoma

17th Jan 2025 08:16

(Alliance News) - AstraZeneca PLC on Friday said its drug Calquence, in combination with chemoimmunotherapy, has received approval from the US Food & Drug Administration for the treatment of adult patients with previously untreated mantle cell lymphoma who are ineligible for stem cell transplantation. Read More

LONDON BRIEFING: Stocks called up but UK retail sales miss forecasts

17th Jan 2025 07:48

(Alliance News) - Stocks were called to open higher on Friday after China recorded one of its slowest rates of economic growth in decades last year, despite outperforming consensus in the fourth quarter. Read More

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

14th Jan 2025 12:07

Hutchmed (China) Ltd - Hong Kong-based biopharmaceutical firm - Says its lung cancer treatment Orpathys has received full approval in China for adult patients. It has been developed in collaboration with AstraZeneca PLC, with Hutchmed leading in China and AZ leading outside of China. The drug was approved by the China National Medical Products Administration for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer. The approval was based on data from the confirmatory phase 3B clinical trial. Read More

LONDON BROKER RATINGS: Deutsche Bank cuts Direct Line to 'hold'

13th Jan 2025 09:37

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug

13th Jan 2025 09:19

(Alliance News) - AstraZeneca PLC on Monday said its lung cancer treatment, co-developed with Daiichi Sankyo Co Ltd, is under priority review for approval by the US Food & Drug Administration. Read More

AstraZeneca breast cancer drug Lynparza given green light for NHS use

9th Jan 2025 11:25

(Alliance News) - Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. Read More

Hutchmed China disposes of 45% stake in Shanghai joint venture

2nd Jan 2025 10:46

(Alliance News) - Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd to GP Health Service Capital Co Ltd and Shanghai Pharmaceuticals Holding Co Ltd, for a total of around USD608 million. Read More

LONDON MARKET MIDDAY: Stocks red ahead of US trade balance read

27th Dec 2024 12:11

(Alliance News) - Stock prices in London were mostly lower at midday on Friday as market participants continue digesting US jobless data and unrest in Mozambique puts miners on edge. Read More

Syncona investee sells assets to AstraZeneca for USD12 million

27th Dec 2024 09:11

(Alliance News) - Syncona Ltd on Friday said one of its investments Achilles Therapeutics PLC has sold its technology assets to AstraZeneca PLC for USD12 million. Read More

LONDON BRIEFING: Stocks seen down as holiday sales stabilise

27th Dec 2024 07:59

(Alliance News) - The FTSE 100 index in London was called slightly lower on Friday, as investors digest holiday-season sales results in the US and UK. Read More

LONDON MARKET OPEN: Vistry plummets on profit warning, Windward soars

24th Dec 2024 09:01

(Alliance News) - Stock prices in London opened higher on Tuesday, injecting some festive cheer into proceedings as markets prepare to close early on Christmas Eve. Read More

101112131415161718
FTSE 100 Latest
Value10,369.75
Change60.53